<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04697459</url>
  </required_header>
  <id_info>
    <org_study_id>2020-09-14</org_study_id>
    <nct_id>NCT04697459</nct_id>
  </id_info>
  <brief_title>Chronic Intradialytic Exercise : a Cardioprotective Role</brief_title>
  <acronym>EX-CHRODIAL</acronym>
  <official_title>Chronic Intradialytic Exercise: a Cardioprotective Role</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Avignon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Avignon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to assess the effects of chronic intradialytic physical exercise on&#xD;
      myocardial remodelling and regional function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Hemodialysis patients have a mortality rate 50 times higher than in the general&#xD;
      population, and the cause remains cardiovascular in more than half of the cases. A&#xD;
      deleterious morphological and functional cardiac remodelling is well established in these&#xD;
      patients, the causes of which are both the presence of factors specific to renal disease&#xD;
      (hemodynamic and non-hemodynamic) and co-morbidities (diabetes, hypertension, etc. .) but&#xD;
      also to the hemodialysis (HD) procedure itself, due to the sudden hemodynamic changes it&#xD;
      imposes, leading to repeated episodes of intradialytic hypotension (HID) and myocardial&#xD;
      stunning. The latter are now documented as direct contributors to the increased mortality&#xD;
      observed in HD patients compared to the general population. The introduction of intradialytic&#xD;
      physical exercise in the therapeutic program of HD patient is now recommended and practised&#xD;
      routinely in many countries, in Scandinavia in particular. Several meta-analyses have clearly&#xD;
      established its safety. The beneficial role of chronic intradialytic exercise in improving&#xD;
      dialysis efficiency, mental health and quality of life, as well as the inflammatory status of&#xD;
      HD patients is also clearly demonstrated. Chronic intradialytic exercise is also associated&#xD;
      with improvements in overall fitness level, a parameter closely linked to cardiovascular&#xD;
      mortality. Applied acutely during dialysis, it could play a cardioprotective role (e.g;&#xD;
      limiting myocardial stunning), allowing haemodynamic and cardiac functional stabilization&#xD;
      during HD. However, to our knowledge, no study to date has investigated the long-term effects&#xD;
      of intradialytic exercise on remodelling and overall and regional heart function.&#xD;
&#xD;
      Aims: The main objective is to assess the effects of chronic intradialytic physical exercise&#xD;
      on myocardial remodelling and regional function. The secondary objectives are to evaluate the&#xD;
      effect of acute intradialytic exercise on myocardial stunning as well as the effect of&#xD;
      chronic physical exercise on macro and microcirculatory vascular function, inflammation,&#xD;
      physical fitness and health-related quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2020</start_date>
  <completion_date type="Anticipated">December 12, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 29, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Acute phase : standard HD versus HD with acute intradialytic exercise (in HD-EX group only);&#xD;
Chronic phase : before and after an exercise training program of 16 weeks (HD-EX group) as well as before and after 16 weeks of standard HD (HD group)</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in myocardial longitudinal deformations</measure>
    <time_frame>Acute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.</time_frame>
    <description>Myocardial longitudinal linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in myocardial longitudinal deformations</measure>
    <time_frame>Chronic phase : before (week 0) and after (week 17) an exercise training program of 16 weeks; each time in the same conditions as in acute phase (e.g. just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise).</time_frame>
    <description>Myocardial longitudinal linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in myocardial circumferential deformations</measure>
    <time_frame>Acute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.</time_frame>
    <description>Myocardial circumferential linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in myocardial circumferential deformations</measure>
    <time_frame>Chronic phase : before (week 0) and after (week 17) an exercise training program of 16 weeks; each time in the same conditions as in acute phase (e.g. just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise).</time_frame>
    <description>Myocardial circumferential linear deformations (in percent) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in left ventricular torsion</measure>
    <time_frame>Acute phase : just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise.</time_frame>
    <description>Left ventricular torsion (in degree) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in left ventricular torsion</measure>
    <time_frame>Chronic phase : before (week 0) and after (week 17) an exercise training program of 16 weeks; each time in the same conditions as in acute phase (e.g. just before and 90 and 210 minutes within standard dialysis or dialysis including acute exercise).</time_frame>
    <description>Left ventricular torsion (in degree) will be assessed by high-resolution echocardiography in deformation imaging mode.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in arterial rigidity</measure>
    <time_frame>before (week 0) and after (week 17) an exercise training program of 16 weeks</time_frame>
    <description>Measurement of pulse wave velocity (m/s) by photo-plethysmography at rest before dialysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Physical fitness</measure>
    <time_frame>before (week 0) and after (week 17) an exercise training program of 16 weeks</time_frame>
    <description>The six-minute walking test (meters); maximal isometric force (newtons) during a knee-extension test and handgrip test using a dynamometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of life</measure>
    <time_frame>before (week 0) and after (week 17) an exercise training program of 16 weeks</time_frame>
    <description>The 36-Item Short Form Health Survey questionnaire. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in carotid intimal-media wall thickness</measure>
    <time_frame>before (week 0) and after (week 17) an exercise training program of 16 weeks</time_frame>
    <description>The intimal plus media wall thickness (mm) of the right carotid artery will be measured using high-resolution echography.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Chronic Renal Failure</condition>
  <arm_group>
    <arm_group_label>HD-EX (patient with intradialytic exercise)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will be enrolled in a 16 week intradilatytic exercise program.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD (patients with standard HD)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients with standard hemodialysis (e.g. without exercise).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>chronic phase</intervention_name>
    <description>1h of intradialytic execise, starting 30 min after hemodialysis beginning : 30 min of low-intensity (Borg Scale 11-14) aerobic exercise + 30 min of resistance training, frequency : 3 times a week for 16 weeks.</description>
    <arm_group_label>HD-EX (patient with intradialytic exercise)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>acute phase</intervention_name>
    <description>30 min of low-intensity (Borg Scale 11-14) aerobic exercise, starting 30 min after hemodialysis beginning</description>
    <arm_group_label>HD-EX (patient with intradialytic exercise)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No medical contraindication to physical activity&#xD;
&#xD;
          -  Life expectancy greater than 6 months&#xD;
&#xD;
          -  Patients on haemodialysis for more than 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
               -  Valvular heart disease,&#xD;
&#xD;
               -  Unstable coronary artery disease&#xD;
&#xD;
               -  Arteriopathy obliterating of the lower limbs stage III and IV&#xD;
&#xD;
               -  Musculoskeletal problems&#xD;
&#xD;
               -  Severe respiratory disease&#xD;
&#xD;
               -  BMI&gt; 35&#xD;
&#xD;
               -  Pacemaker, cardiac stimulation and automatic implantable defibrillator&#xD;
&#xD;
               -  Heart transplant&#xD;
&#xD;
               -  Uncontrolled arterial hypertension&#xD;
&#xD;
               -  Ejection fraction &lt;45%&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Obert, Pr.</last_name>
    <role>Study Chair</role>
    <affiliation>Avignon University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe OBERT, Pr.</last_name>
    <phone>+33698050446</phone>
    <email>philippe.obert@univ-avignon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hemodialyse AIDER sante</name>
      <address>
        <city>NÃ®mes</city>
        <state>Gard</state>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure Patrier, Dr</last_name>
      <phone>+334 30 81 13 20</phone>
      <email>l.patrier@aidersante.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ATIR</name>
      <address>
        <city>Avignon</city>
        <state>Vaucluse</state>
        <zip>84000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myriam Isnard, Dr.</last_name>
      <phone>+334 90 88 82 72</phone>
      <email>myriam.isnard@orange.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 4, 2021</last_update_submitted>
  <last_update_submitted_qc>January 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exercise</keyword>
  <keyword>hemodialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

